High Vitamin D Doses During Pregnancy May Make Little Difference to Risks

Key Clinical Takeaways:

• Supplements above 600 IU/day show little effect on major pregnancy complications.
• Doses at the 4000 IU/day upper safe limit or higher also show minimal impact on these risks.
• Researchers note uncertainty regarding unwanted effects and call for longer-term child follow-ups.

Why Vitamin D Matters

Vitamin D helps the body maintain bone strength, regulate growth, and support the immune system. The body produces it naturally when sunlight hits the skin, and it is also found in foods such as oily fish, red meat, and eggs. Vitamin D deficiency remains common worldwide, especially in low- and middle-income nations.

Low vitamin D levels during pregnancy link to several health problems for mothers and infants. These complications include pre-eclampsia, which involves high blood pressure and organ damage, along with gestational diabetes. Other risks involve preterm birth before 37 weeks and low birthweight, which can occasionally prove fatal.

What the Review Tested

Researchers wanted to find out if taking vitamin D supplements above the recommended daily amount of 600 international units per day provides benefits. They also checked for negative health effects from taking supplements at the upper safe limit of 4000 IU/day or higher. The team searched for studies evaluating these specific doses in pregnant women.

The review identified 25 studies involving 7,008 women. The smallest study included 24 participants, while the largest involved 1,300. Conducted between 2004 and 2024 across Asia, Europe, North America, and Oceania, the trials lasted between 12 and 28 weeks.

Results Across Different Doses

Nineteen studies involving 5,141 women evaluated doses higher than 600 IU/day compared with 600 IU/day or less. These higher doses may make little or no difference to the risk of pre-eclampsia across 8 studies of 2,629 women. They also show little difference for gestational diabetes, preterm birth, and low birthweight.

Fourteen studies involving 4,954 women evaluated doses of 4,000 IU/day or more compared with lower amounts. These upper-limit doses may make little or no difference to pre-eclampsia, gestational diabetes, and preterm birth. They probably make little or no difference to low birthweight, according to 3 studies involving 1,637 infants.

Researchers Lack Evidence on Unwanted Effects

Most studies reported no unwanted effects or no differences in unwanted effects between women receiving different doses. Investigated effects included abnormal calcium levels in blood or urine, as well as hospitalizations. However, researchers remain uncertain whether supplementation causes unwanted effects for women and infants.

The review team has little confidence in most of the evidence. Too few studies exist to be certain about combined results, and participants in some trials knew which treatment they received. Most studies took place in high-income countries, and dosing schedules varied widely.

Future Research Plans

Future studies should follow babies and children longer after birth. This tracking will help researchers understand the long-term health effects of maternal vitamin D supplementation.

This review updates a previous 2019 assessment and current evidence runs up to April 2026.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.